Advertisement

Child’s Nervous System

, Volume 22, Issue 3, pp 320–324 | Cite as

Widened clinical spectrum of the Q128P MECP2 mutation in Rett syndrome

  • P. F. GiampietroEmail author
  • D. B. Schowalter
  • S. Merchant
  • L. R. Campbell
  • T. Swink
  • B. B. Roa
Case Report

Abstract

Case report

We describe a female patient with Arnold Chiari type I malformation, atypical Rett syndrome characterized by postnatal onset microcephaly, stereotypic hand movements, ataxia, severe developmental delay, intractable tonic–clonic seizures, and a MECP2 mutation with a unique set of clinical findings. Implementation of a ketogenic diet resulted in decreased seizure activity and an improvement in the patient’s degree of social relatedness with her family members.

Discussion

An early diagnosis of Rett syndrome allows families to maximize utilization of existing treatment modalities and seek appropriate genetic counseling and prenatal diagnoses. This case also provides further evidence for the treatment benefit of ketogenic diets for seizures in patients with Rett syndrome.

Keywords

Rett syndrome Type 1 Chiari malformation MECP2 Ketogenic diet 

Notes

Acknowledgements

The authors thank Marshfield Clinic Research Foundation for its support through the assistance of Jennifer Hayes, Linda Weis, and Alice Stargardt in the preparation of this manuscript.

References

  1. 1.
    Amano K, Nomura Y, Segawa M, Yamakawa K (2000) Mutational analysis of the MECP2 gene in Japanese patients with Rett syndrome. J Hum Genet 45:231–236PubMedCrossRefGoogle Scholar
  2. 2.
    Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23:185–188PubMedCrossRefGoogle Scholar
  3. 3.
    Coy JF, Sedlacek Z, Bachner D, Delius H, Poustka A (1999) A complex pattern of evolutionary conservation and alternative polyadenylation within the long 3″-untranslated region of the methyl-CpG-binding protein 2 gene (MeCP2) suggests a regulatory role in gene expression. Hum Mol Genet 8:1253–1262PubMedCrossRefGoogle Scholar
  4. 4.
    Ellaway CJ, Badawi N, Raffaele L, Christodoulou J, Leonard H (2001) A case of multiple congenital anomalies in association with Rett syndrome confirmed by MECP2 mutation screening. Clin Dysmorphol 10:185–188PubMedCrossRefGoogle Scholar
  5. 5.
    Goutieres F, Aicardi J (1986) Atypical forms of Rett syndrome. Am J Med Genet Suppl 1:183–194PubMedCrossRefGoogle Scholar
  6. 6.
    Haas RH, Rice M (1985) Is Rett’s syndrome a disorder of carbohydrate metabolism? Hyperpyruvic acidemia and treatment by a ketogenic diet. Ann Neurol 18:418Google Scholar
  7. 7.
    Haas RH, Rice MA, Trauner DA, Merritt TA (1986) Therapeutic effects of a ketogenic diet in Rett syndrome. Am J Med Genet Suppl 24:225–246CrossRefGoogle Scholar
  8. 8.
    Inui K, Akagi M, Ono J, Tsukamoto H, Shimono K, Mano T, Imai K, Yamada M, Muramatsu T, Sakai N, Okada S (2001) Mutational analysis of MECP2 in Japanese patients with atypical Rett syndrome. Brain Dev 23:212–215PubMedCrossRefGoogle Scholar
  9. 9.
    Liebhaber GM, Riemann E, Baumeister FA (2003) Ketogenic diet in Rett syndrome. J Child Neurol 18:74–75PubMedCrossRefGoogle Scholar
  10. 10.
    Lugaresi E, Cirignotta F, Montagna P (1985) Abnormal breathing in the Rett syndrome. Brain Dev 7:329–333PubMedCrossRefGoogle Scholar
  11. 11.
    Percy AK (2002) Clinical trials and treatment prospects. Ment Retard Dev Disabil Res Rev 8:106–111PubMedCrossRefGoogle Scholar
  12. 12.
    Reiss AL, Faruque F, Naidu S, Abrams M, Beaty T, Bryan RN, Moser H (1993) Neuroanatomy of Rett syndrome: a volumetric imaging study. Ann Neurol 34:227–234PubMedCrossRefGoogle Scholar
  13. 13.
    Schanen C, Houwink EJ, Dorrani N, Lane J, Everett R, Feng A, Cantor RM, Percy A (2004) Phenotypic manifestations of MECP2 mutations in classical and atypical Rett syndrome. Am J Med Genet 126A:129–140PubMedCrossRefGoogle Scholar
  14. 14.
    Shibayama A, Cook EH Jr, Feng J, Glanzmann C, Yan J, Craddock N, Jones IR, Goldman D, Heston LL, Sommer SS (2004) MECP2 structural and 3′-UTR variants in schizophrenia, autism and other psychiatric diseases: a possible association with autism. Am J Med Genet 128B:50–53PubMedCrossRefGoogle Scholar
  15. 15.
    Smeets E, Schollen E, Moog U, Matthijs G, Herbergs J, Smeets H, Curfs L, Schrander-Stumpel C, Fryns JP (2003) Rett syndrome in adolescent and adult females: clinical and molecular genetic findings. Am J Med Genet 122A:227–233PubMedCrossRefGoogle Scholar
  16. 16.
    Swink TD, Vining EP, Freeman JM (1997) The ketogenic diet: 1997. Adv Pediatr 44:297–329PubMedGoogle Scholar
  17. 17.
    Wan M, Lee SS, Zhang X, Houwink-Manville I, Song HR, Amir RE, Budden S, Naidu S, Pereira JL, Lo IF, Zoghbi HY, Schanen NC, Francke U (1999) Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots. Am J Hum Genet 65:1520–1529PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  • P. F. Giampietro
    • 1
    Email author
  • D. B. Schowalter
    • 2
  • S. Merchant
    • 3
  • L. R. Campbell
    • 4
  • T. Swink
    • 4
  • B. B. Roa
    • 5
  1. 1.Department of Medical Genetic ServicesMarshfield ClinicMarshfieldUSA
  2. 2.Medical GeneticsMayo ClinicRochesterUSA
  3. 3.Department of Medical GeneticsUniversity of AlbertaEdmontonCanada
  4. 4.Department of Pediatric NeurologyMarshfield ClinicMarshfieldUSA
  5. 5.Department of Molecular and Human GeneticsBaylor College of MedicineHoustonUSA

Personalised recommendations